Cadrenal Therapeutics (CVKD) Projected to Post Quarterly Earnings on Thursday

Chronological Source Flow
Back

AI Fusion Summary

Cadrenal Therapeutics (CVKD) is scheduled to release its Q4 2025 earnings before the market opens on Thursday, March 12th. Analysts are projecting a loss of $1.21 per share for the quarter.
05/03 08:54 defenseworld.net
4 Πηγές
05/03 09:10 defenseworld.net
05/03 09:10 defenseworld.net
05/03 09:10 defenseworld.net
Comments
Loading...
0